-
The UK Department of Health has instituted measures they believe will prevent hospital acquired infections.
-
A nested PCR Method was used to identify and speciate cases of malaria in two regions of Malaysia. This study showed a significant proportion of patients to have been infected with P. knowlesi, a pathogen of Old World macaques and previously rarely recognized in humans.
-
Acute sinusitis is a common presenting complaint in primary care; most cases are treated with oral antibiotics despite controversy as to whether such treatment is effective.
-
The infectious diseases group at Walter Reed reported the clinical cases of 4 patients who acquired visceral leishmaniasis during deployments to either Afghanistan (two patients) or Iraq (two patients).
-
In this issue: Rosiglitazone (Avandia) implicated in yet another study; Prilosec and Nexium not associated with cardiac events; Anastrozole (Arimidex) shown more effective than tamoxifen for treatment of early-stage breast cancer; antibiotics show no effect on sinusitis; FDA actions.
-
The Centers for Disease Control and Prevention in conjunction with Kaiser Permanente's Northern California Division of Research will formally investigate an unexplained but persistently reported skin condition known as Morgellons.
-
A recent controversial move by a federal health agency to shut down a highly successful infection prevention program because it appeared to be involved in human research rather than quality improvement has ominous implications for traditional infection control activities, a leading epidemiologist tells Hospital Infection Control.
-
-
The Michigan Health & Hospital Association's Keystone Center for Patient Safety & Quality has created a "bladder bundle" of measures to prevent urinary tract infections. Some of the key recommendations for implementation of the bundle are summarized as follows:
-
Merck & Co. has initiated a voluntary recall in the United States for 10 lots of PedvaxHIB® [Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)] and two lots of COMVAX® [Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine].